Almirall, Forest Get EU, FDA Nods For COPD Treatment
The twice-daily inhaled dry powder, aclidinium bromide, helps treat bronchospasms, or the constricting of airways, that occur during COPD. The treatment will be sold under the name Tudorza Pressair in the U.S. and Eklira/Bretaris Genuair in the EU.
COPD, which includes chronic bronchitis and emphysema, is an inflammation of the airways that is often associated with smoking. The...
To view the full article, register now.